Investor Ideas Adds New Nasdaq
Stocks in Biotech- $RLAY, $IVA, $NKTX, $PSTX
New CSE Stocks in Mining
(CSE: $CC.C) (CSE: $LIDO.C)
Point Roberts WA, Delta BC, July 31, 2020 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading retail investor resource announces its weekly roundup of stocks added
to its global stock directories, including biotech and mining.
Read this in full at https://www.investorideas.com/news/2020/main/07311Stocks.asp
This week’s new biotech companies are all Nasdaq IPOs
from July.
The latest mining companies are new listings from
the CSE (Canadian Stock Exchange).
New Stocks added to
Biotech stocks directory
Relay
Therapeutics, Inc. (NasdaqGS:RLAY) is a clinical-stage precision medicines company
transforming the drug discovery process with the goal of bringing life-changing
therapies to patients. Built on unparalleled insights into protein motion and
how this dynamic behavior relates to protein function, Relay Therapeutics aims
to effectively drug protein targets that have previously been intractable, with
an initial focus on enhancing small molecule therapeutic discovery in targeted
oncology. The Company’s Dynamo platform integrates an array of leading-edge
experimental and computational approaches to provide a differentiated
understanding of protein structure and motion to drug these targets.
Inventiva S.A. (NasdaqGM:IVA) is a
clinical-stage biopharmaceutical company focused on the development of oral
small molecule therapies for the treatment of NASH, MPS and other diseases with
significant unmet medical need. Leveraging its expertise and experience in the
domain of compounds targeting nuclear receptors, transcription factors and
epigenetic modulation, Inventiva is currently advancing two clinical
candidates, as well as a deep pipeline of earlier stage programs. Lanifibranor,
its lead product candidate, is being developed for the treatment of patients
with NASH, a common and progressive chronic liver disease for which there are
currently no approved therapies. Inventiva recently announced positive topline
data from its Phase IIb clinical trial evaluating lanifibranor for the
treatment of patients with NASH. Inventiva is also developing odiparcil, a
second clinical stage asset, for the treatment of patients with subtypes of
MPS, a group of rare genetic disorders. A Phase I/II clinical trial in children
with MPS VI is currently under preparation following the release of positive
results of the Phase IIa clinical trial in adult MPS VI patients at the end of
2019. In parallel, Inventiva is in the process of selecting an oncology
development candidate for its Hippo signalling pathway program. Furthermore,
the Company has established a strategic collaboration with AbbVie in the area
of autoimmune diseases. AbbVie has started the clinical development of ABBV‑157, a drug
candidate for the treatment of moderate to severe psoriasis resulting from its
collaboration with Inventiva. This collaboration enables Inventiva to receive
milestone payments upon the achievement of pre-clinical, clinical, regulatory
and commercial milestones, in addition to royalties on any approved products
resulting from the collaboration.
Nkarta,
Inc. (NasdaqGS:NKTX) focuses on combining its natural killer (NK) cell
expansion and cryopreservation platform with proprietary cell engineering
technologies to generate an abundant supply of NK cells, engineer enhanced NK
cell recognition of tumor targets, and improve persistence for sustained
activity in the body for the treatment of cancer. Nkarta’s mission is to
discover, develop and deliver novel off-the-shelf NK cell therapy product
candidates that have a profound impact on patients.
Poseida
Therapeutics, Inc. (NasdaqGS:PSTX) is a clinical-stage biopharmaceutical company
dedicated to utilizing our proprietary gene engineering platform technologies
to create next generation cell and gene therapeutics with the capacity to cure.
We have discovered and are developing a broad portfolio of product candidates
in a variety of indications based on our core proprietary platforms, including
our non-viral piggyBac® DNA Modification System, Cas-CLOVER™ site-specific gene
editing system and nanoparticle- and AAV-based gene delivery technologies. Our
core platform technologies have utility, either alone or in combination, across
many cell and gene therapeutic modalities and enable us to engineer our
wholly-owned portfolio of product candidates that are designed to overcome the
primary limitations of current generation cell and gene therapeutics.
New Stocks added to
Mining stocks directory
Core Assets Corp. (CSE:CC) is focused
on the global acquisition, exploration, development and mining of mineral
properties. The company's current focus is the exploration and development of
the Blue Property, located 48 km SW of Atlin, BC which is believed to be prospective
for copper, cobalt, silver and gold.
Lido Minerals Ltd. (CSE:LIDO) is a Canadian based mineral exploration company,
actively involved the exploration of the Nimpkish properties on Vancouver
Island
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized
news source publishing third party news and press releases, research and our
own original financial content. We were one of the first retail investor sites
to cover renewable energy and cleantech stocks at investorideas.com and our
domain Renewableenergystocks.com. We were also one of the most well- known and
cited defense stock sites, featuring our domain Homelanddefensestocks.com at
its peak.
We follow the money for
investors as sector sentiment shifts and technology disrupts. Our mission is to
provide investor ideas with breaking news, resources, industry articles and
interviews with leading experts.
Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking
at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy and more. Investor Idea's original branded content includes the
following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the
sectors we cover use our news and content services to tell their story to interested investors.
Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media
services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club
https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
No comments:
Post a Comment